Reduction of fatty liver in rats by nicotinamide via the regeneration of the methionine cycle and the inhibition of aldehyde oxidase
- 1 January 2021
- journal article
- research article
- Published by Japanese Society of Toxicology in The Journal of Toxicological Sciences
- Vol. 46 (1), 31-42
- https://doi.org/10.2131/jts.46.31
Abstract
Nonalcoholic fatty liver disease, which has been rapidly increasing in the world in recent years, is roughly classified into nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis. This study was based on our previous reports that stated that the combination treatment of N1-methylnicotinamide (MNA) and hydralazine (HYD) improves fatty liver in NAFL model rats. This finding was attributed to the MNA metabolism inhibition by HYD, which is a strong inhibitor of aldehyde oxidase (AO); this results in an increase in hepatic MNA and improved fatty liver. We hypothesized that orally administered nicotinamide (NAM), which is the precursor of MNA and is a form of niacin, would be efficiently metabolized by nicotinamide N-methyltransferase in the presence of exogenous S-adenosylmethionine (SAM) in NAFL rats. To address this issue, NAFL model rats were orally administered with NAM, SAM, and/or HYD. As a result, liver triglyceride (TG) and lipid droplet levels were barely altered by the administration of NAM, SAM, NAM+SAM, or NAM+HYD. By contrast, the triple combination of NAM+SAM+HYD significantly reduced hepatic TG and lipid droplet levels and significantly increased hepatic MNA levels. These findings indicated that the combination of exogenous SAM with AO inhibitors, such as HYD, has beneficial effects for improving fatty liver with NAM.Keywords
This publication has 43 references indexed in Scilit:
- Effect of Nonalcoholic Fatty Liver Disease on the Development of Type 2 Diabetes in Nonobese, Nondiabetic Korean MenGut and Liver, 2012
- Nitric Oxide Production and Endothelium-Dependent Vasorelaxation Ameliorated by N 1 -Methylnicotinamide in Human Blood VesselsHypertension, 2012
- The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative studyHepatology, 2011
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver diseaseNature Genetics, 2008
- Plasma and urine pharmacokinetics of niacin and its metabolites from an extended-release niacin formulationInternational journal of clinical pharmacology and therapeutics, 2007
- Topical application of 1-methylnicotinamide in the treatment of rosacea: a pilot studyClinical and Experimental Dermatology, 2005
- Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of inflammation-related genesDiabetologia, 2005
- Design and validation of a histological scoring system for nonalcoholic fatty liver diseaseHepatology, 2005
- Effect of the variations of S-adenosyl--methionine liver content on fat accumulation and ethanol metabolism in ethanol-intoxicated ratsToxicology and Applied Pharmacology, 1986
- Species variations in theN-methylation and quaternization of [14C]pyridineXenobiotica, 1980